SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Unquoted Biotechs

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Ian@SI1/16/2007 9:59:08 AM
   of 253
 
genizon.com
Venture fund investors list: genizon.com

+++++++++++++++++++++++++++++++++

Pfizer, Genizon BioSciences In License, Discovery Pact

DOW JONES NEWSWIRES

Pfizer Inc. (PFE) signed a license and collaboration agreement with Genizon BioSciences for diagnostic rights to Genizon's discovery programs in Alzheimer's disease, attention deficit hyperactivity disorder and endometriosis.

Genizon, a Quebec, Canada, gene mapping company, said Tuesday it will retain therapeutic rights.

Terms of the deal weren't disclosed.

Pfizer, a New York pharmaceutical company, agreed to pay Genizon upfront license fees and funding for research on genetic variations associated with diseases. Pfizer will also buy an equity stake in Genizon, the Canadian company said.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext